SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-076989
Filing Date
2021-03-11
Accepted
2021-03-11 07:05:51
Documents
3
Period of Report
2021-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d83136d8k.htm 8-K 18059
2 EX-99.1 d83136dex991.htm EX-99.1 52814
3 GRAPHIC g83136galera.jpg GRAPHIC 4638
  Complete submission text file 0001193125-21-076989.txt   78505
Mailing Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355
Business Address 2 WEST LIBERTY BLVD #100 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39114 | Film No.: 21731825
SIC: 2834 Pharmaceutical Preparations